Journal article
The effect of medroxyprogesterone acetate (Provera) on ovarian radiosensitivity
Abstract
Medroxyprogesterone acetate (Provera) is a drug that is commonly given to young women with cancer during chemotherapy and radiation to control heavy bleeding associated with anovulation. Because hypothalamic-pituitary-ovarian suppression has been associated with ovarian protection from the effects of chemotherapy and medroxyprogesterone acetate has been identified as a radiosensitizing agent, we explored the effects of medroxyprogesterone …
Authors
Jarrell J; YoungLai EV; McMahon A; Barr R; O'Connell G; Belbec L
Journal
American Journal of Obstetrics and Gynecology, Vol. 160, No. 4, pp. 990–994
Publisher
Elsevier
Publication Date
4 1989
DOI
10.1016/0002-9378(89)90322-0
ISSN
0002-9378